Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionTrexquant Investment LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Trexquant Investment LP closes position in LGND / Ligand Pharmaceuticals Incorporated

On May 15, 2026 - Trexquant Investment LP filed a 13F-HR form disclosing ownership of 0 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 11,550 shares of Ligand Pharmaceuticals Incorporated. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -100.00 0
2026-02-17 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 11,550 -32,949 -74.04 2,184 -72.30 0.0195
2025-11-14 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 44,499 44,499 7,883 0.0811
2023-11-13 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -21,267 -100.00 0 -100.00
2023-08-11 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 21,267 4,916 30.07 1,533 27.54 0.0402
2023-05-15 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 16,351 -7,178 -30.51 1,203 -23.49 0.0330
2023-02-13 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 23,529 7,795 49.54 1,572 15.94 0.0446
2022-11-14 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 15,734 11,060 236.63 1,355 224.94 0.0476
2022-08-11 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,674 4,674 417 0.0187
2022-05-13 2022-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -3,680 -100.00 0 -100.00
2022-02-14 2021-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,680 3,680 568 0.0351
2021-02-11 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -6,611 -100.00 0 -100.00
2020-11-06 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,611 1,109 20.16 630 2.44 0.0405
2020-08-07 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,502 -6,703 -54.92 615 -30.74 0.0427
2020-05-08 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 12,205 12,205 888 0.0644
2020-02-12 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -3,324 -100.00 0 -100.00
2020-02-18 2019-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 3,324 -782 -19.05 331 -29.42 0.0286
2019-11-08 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,324 -782 331 28,587.6163
2019-08-09 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,106 4,106 469 0.0422
2019-05-13 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -26,987 -100.00 0 -100.00
2019-02-13 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 26,987 21,214 367.47 3,662 131.04 0.2289
2018-11-09 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,773 5,773 1,585 0.1192
2015-08-12 2015-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 0 -7,100 -100.00 0 -100.00
2015-05-13 2015-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 7,100 -3,292 -31.68 547 -0.91 0.0558
2015-02-13 2014-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 10,392 10,392 552 0.0976
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.